查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1941795

人工智慧診斷市場規模、佔有率和趨勢分析報告：按組件、診斷類型、地區和細分市場分類，預測期為 2026 年至 2033 年

Artificial Intelligence In Diagnostics Market Size, Share & Trends Analysis Report By Component, By Diagnosis Type, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

人工智慧診斷市場概述

預計到 2025 年，全球人工智慧診斷市場規模將達到 19.7 億美元，到 2033 年將達到 96.8 億美元。

預計從 2026 年到 2033 年，該市場將以 21.74% 的複合年成長率成長。這一市場成長主要由機器學習和深度學習的進步所驅動，這些進步使得更快、更準確的診斷解決方案成為可能。

在腫瘤學、心臟病學和神經病學等領域，對疾病早期檢測日益成長的需求正在推動人工智慧技術的應用。例如，2024年2月，皇家飛利浦發布了飛利浦CT 5300，這是一款先進的人工智慧CT系統，專為診斷、介入治療和篩檢設計。這款高度靈活的X光CT系統可提高診斷準確度、簡化工作流程並最佳化系統運轉率。

糖尿病、癌症和心血管疾病等慢性病盛行率的上升，以及對早期精準診斷需求的日益成長，是推動市場成長的主要因素。全球癌症發生率的上升導致腫瘤學領域對人工智慧的依賴性增強。根據美國國立衛生研究院 (NIH) 2023 年的估計，美國約有 200 萬人被診斷出罹患癌症。乳癌是最常見的癌症，估計女性病例為 297,790 例，男性病例為 2,800 例。同樣，根據美國疾病管制與預防中心 (CDC) 的數據，2023 年美國有 919,032 人死於心血管疾病，佔所有死亡人數的三分之一。

如此高的發病率增加了診斷工作量。醫療IT基礎設施的進步以及雲端運算、運算和機器學習演算法的持續技術發展，正推動人工智慧系統與診斷的融合，從而提供高效精準的診斷。這使得醫療服務提供者能夠制定及時有效的治療方案。基於人工智慧的演算法正在病理學和放射學領域中廣泛應用。例如，2026年1月，Alpenglow Biosciences和Passnet達成策略合作，共同開發和商業化用於前列腺癌和膀胱癌的3D人工智慧診斷測試。此次合作將推動美國泌尿系統腫瘤學從2D病理學邁向3D病理學，透過整合影像診斷、人工智慧分析和工作流程，提高診斷準確度。

「PathNet在泌尿系統腫瘤學、數位化和人工智慧領域的領先地位，以及其強大的全國性影響力，使其成為將臨床3D病理學推向市場的理想合作夥伴。兩家公司正在攜手開發診斷工具，提供傳統2D組織學無法獲得的洞見。”

執行長

此外，多種人工智慧工具正被應用於慢性腎臟病（CKD）、腎功能檢測以及各種慢性疾病的診斷。例如，2024年5月，Premier Inc.與Astra Zeneca合作啟動了「Uncover CKD-Care Collective」舉措。該舉措旨在識別未確診的CKD患者，提高醫療服務提供者的認知，並幫助美國醫療系統改善CKD的診斷、治療和管理。透過利用Premier Inc.的PINC人工智慧技術和服務平台，我們將應對CKD未確診病例日益增多的趨勢及其對美國醫療系統帶來的經濟負擔。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：人工智慧在診斷領域的市場變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 用於診斷的人工智慧市場分析工具
    • 產業分析：波特五力模型
    • PESTEL 分析
  • 案例研究的啟示

第4章：人工智慧診斷市場：按組件分類的估算與趨勢分析

  • 按組件分類的市場佔有率（2025 年和 2033 年）
  • 全球人工智慧診斷市場：基於組件的展望
  • 軟體
  • 硬體
  • 服務

第5章：人工智慧診斷市場：按診斷類型分類的估算與趨勢分析

  • 按診斷類型分類的市場佔有率（2025 年和 2033 年）
  • 全球人工智慧診斷市場：按診斷類型分類的展望
  • 心臟病
  • 瘤
  • 病理
  • 輻射
  • 胸部/肺部
  • 神經
  • 其他

第6章：人工智慧診斷市場：區域估算與趨勢分析

  • 區域市場佔有率分析（2025 年和 2033 年）
  • 區域市場概覽
  • 全球市場概覽（按地區分類）
  • 市場規模及預測趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭情勢

  • Competitor Growth Readiness Index（GRI）, 2025
  • Competitor Capability Matrix, 2025
  • 公司分類
  • 企業市場分析
  • 策略規劃
  • 公司簡介/列表
    • Key company market share analysis, 2025
    • Siemens Healthineers
    • Zebra Technologies Corp.
    • Riverain Technologies
    • Vuno, Inc.
    • Aidoc
    • NovaSignal Corporation（previously known as Neural Analytics, acquired by NeuraSignal, Inc.）
    • Koninklijke Philips NV
    • Digital Diagnostics, Inc.
    • GE Healthcare
    • AliveCor Inc.
    • F. Hoffmann-La Roche Ltd
Product Code: GVR-4-68038-871-8

Artificial Intelligence In Diagnostics Market Summary

The global artificial intelligence in diagnostics market size was estimated at USD 1.97 billion in 2025 and is projected to reach USD 9.68 billion by 2033, growing at a CAGR of 21.74% from 2026 to 2033. Market growth is driven by advancements in machine learning and deep learning, enabling faster, more accurate diagnostic solutions.

In oncology, cardiology, and neurology, among the areas, the growing demand for early disease detection has led to increased adoption of AI technologies. For instance, in February 2024, Royal Philips introduced the Philips CT 5300, an advanced AI-powered CT system designed for diagnostics, interventional procedures, and screenings. The adaptable X-ray CT system enhances diagnostic accuracy, streamlines workflows, and optimizes system availability.

Rising prevalence of chronic diseases such as diabetes, cancer, cardiovascular disorders, etc., coupled with the increasing demand for early & accurate diagnosis, are significant factors driving market growth. The increasing incidence of cancer globally has led to a growing dependence on AI in the field of oncology. According to the NIH estimates of 2023, approximately 2.0 million individuals in the U.S. are diagnosed with cancer. Breast cancer was the most diagnosed cancer, with an estimated 297,790 cases in women and 2,800 cases in men. Similarly, according to the Centers for Disease Control and Prevention (CDC), 919,032 people died from cardiovascular disease in the U.S. in 2023, equivalent to one in every three deaths.

Such a high prevalence increases the diagnostic workload. Advancements in healthcare IT infrastructure and ongoing technological developments in cloud storage, computing, and machine learning algorithms support the integration of AI-powered systems into diagnostics to provide efficient & accurate diagnoses, allowing care providers to devise timely & appropriate treatment plans. Pathology and radiology services are witnessing a widespread adoption of AI-based algorithms. For instance, in January 2026, Alpenglow Biosciences and PathNet formed a strategic partnership to develop and commercialize 3D AI diagnostic tests for prostate and bladder cancer. The collaboration advances urologic oncology from 2D to 3D pathology in the U.S., integrating imaging, AI analytics, and workflows for enhanced accuracy.

"PathNet's leadership in urologic oncology, digitization, AI, and strong national footprint make them an exceptional partner as we bring clinical 3D pathology to market. Together, we are building diagnostic tools that deliver insights not achievable with conventional 2D histology."

Dr. Nicholas Reder, CEO of Alpenglow Biosciences

In addition, several AI-powered tools are used to diagnose chronic kidney disease (CKD) & kidney function tests, and various chronic diseases. For instance, in May 2024, Premier, Inc. partnered with AstraZeneca to launch the Uncover CKD - Care Collective initiative. The aim is to identify patients with undiagnosed CKD, raise awareness among healthcare providers, and assist U.S. health systems in improving their CKD diagnosis, treatment, and management. Leveraging Premier's PINC AI technology and services platform, the initiative seeks to address the increasing prevalence of undiagnosed CKD and its associated economic burden on the U.S. healthcare system.

Global Artificial Intelligence In Diagnostics Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global artificial intelligence in diagnostics market report based on component, diagnosis type, and region:

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
  • Hardware
  • Services
  • Diagnosis Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Cardiology
  • Oncology
  • Pathology
  • Radiology
  • Chest and Lung
  • Neurology
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Component
    • 1.1.2. Diagnosis type
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Component outlook
    • 2.2.2. Diagnosis type outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Artificial Intelligence In Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. Artificial Intelligence In Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape
  • 3.4. Case Study Insights

Chapter 4. Artificial Intelligence In Diagnostics Market: Component Estimates & Trend Analysis

  • 4.1. Component Market Share, 2025 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global Artificial Intelligence In Diagnostics Market, By Component Outlook
  • 4.4. Software
    • 4.4.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 4.5. Hardware
    • 4.5.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 4.6. Services
    • 4.6.1. Market estimates and forecast, 2021 to 2033 (USD Million)

Chapter 5. Artificial Intelligence In Diagnostics Market: Diagnosis Type Estimates & Trend Analysis

  • 5.1. Diagnosis Type Market Share, 2025 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Global Artificial Intelligence In Diagnostics Market, By Diagnosis Type Outlook
  • 5.4. Cardiology
    • 5.4.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 5.5. Oncology
    • 5.5.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 5.6. Pathology
    • 5.6.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 5.7. Radiology
    • 5.7.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 5.8. Chest and Lung
    • 5.8.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 5.9. Neurology
    • 5.9.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 5.10. Others
    • 5.10.1. Market estimates and forecast, 2021 to 2033 (USD Million)

Chapter 6. Artificial Intelligence In Diagnostics Market: Regional Estimates & Trend Analysis, By Component, By Diagnosis Type

  • 6.1. Regional Market Share Analysis, 2025 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Singapore market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Competitor Growth Readiness Index (GRI), 2025
  • 7.2. Competitor Capability Matrix, 2025
  • 7.3. Company Categorization
  • 7.4. Company Market Position Analysis
  • 7.5. Strategy Mapping
  • 7.6. Company Profiles/Listing
    • 7.6.1. Key company market share analysis, 2025
    • 7.6.2. Siemens Healthineers
      • 7.6.2.1. Company overview
      • 7.6.2.2. Financial performance
      • 7.6.2.3. Product benchmarking
      • 7.6.2.4. Strategic initiatives
    • 7.6.3. Zebra Technologies Corp.
      • 7.6.3.1. Company overview
      • 7.6.3.2. Financial performance
      • 7.6.3.3. Product benchmarking
      • 7.6.3.4. Strategic initiatives
    • 7.6.4. Riverain Technologies
      • 7.6.4.1. Company overview
      • 7.6.4.2. Financial performance
      • 7.6.4.3. Product benchmarking
      • 7.6.4.4. Strategic initiatives
    • 7.6.5. Vuno, Inc.
      • 7.6.5.1. Company overview
      • 7.6.5.2. Financial performance
      • 7.6.5.3. Product benchmarking
      • 7.6.5.4. Strategic initiatives
    • 7.6.6. Aidoc
      • 7.6.6.1. Company overview
      • 7.6.6.2. Financial performance
      • 7.6.6.3. Product benchmarking
      • 7.6.6.4. Strategic initiatives
    • 7.6.7. NovaSignal Corporation (previously known as Neural Analytics, acquired by NeuraSignal, Inc.)
      • 7.6.7.1. Company overview
      • 7.6.7.2. Financial performance
      • 7.6.7.3. Product benchmarking
      • 7.6.7.4. Strategic initiatives
    • 7.6.8. Koninklijke Philips N.V.
      • 7.6.8.1. Company overview
      • 7.6.8.2. Financial performance
      • 7.6.8.3. Product benchmarking
      • 7.6.8.4. Strategic initiatives
    • 7.6.9. Digital Diagnostics, Inc.
      • 7.6.9.1. Company overview
      • 7.6.9.2. Financial performance
      • 7.6.9.3. Product benchmarking
      • 7.6.9.4. Strategic initiatives
    • 7.6.10. GE Healthcare
      • 7.6.10.1. Company overview
      • 7.6.10.2. Financial performance
      • 7.6.10.3. Product benchmarking
      • 7.6.10.4. Strategic initiatives
    • 7.6.11. AliveCor Inc.
      • 7.6.11.1. Company overview
      • 7.6.11.2. Financial performance
      • 7.6.11.3. Product benchmarking
      • 7.6.11.4. Strategic initiatives
    • 7.6.12. F. Hoffmann-La Roche Ltd
      • 7.6.12.1. Company overview
      • 7.6.12.2. Financial performance
      • 7.6.12.3. Product benchmarking
      • 7.6.12.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 4. Global AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 5. North America AI in diagnostics market, by country, 2021 - 2033 (USD Million)
  • Table 6. North America AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 7. North America AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 8. U.S. AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 9. U.S. AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 10. Canada AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 11. Canada AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 12. Mexico AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 13. Mexico AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 14. Europe AI in diagnostics market, by country, 2021 - 2033 (USD Million)
  • Table 15. Europe AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 16. Europe AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 17. UK AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 18. UK AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 19. Germany AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 20. Germany AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 21. France AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 22. France AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 23. Italy AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 24. Italy AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 25. Spain AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 26. Spain AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 27. Norway AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 28. Norway AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 29. Denmark AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 30. Denmark AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 31. Sweden AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 32. Sweden AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 33. Asia Pacific AI in diagnostics market, by country, 2021 - 2033 (USD Million)
  • Table 34. Asia Pacific AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 35. Asia Pacific AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 36. Japan AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 37. Japan AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 38. China AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 39. China AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 40. India AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 41. India AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 42. Australia AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 43. Australia AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 44. South Korea AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 45. South Korea AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 46. Thiland AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 47. Thailand AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 48. Latin America AI in diagnostics market, by country, 2021 - 2033 (USD Million)
  • Table 49. Latin America AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 50. Latin America AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 51. Brazil AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 52. Brazil AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 53. Argentina AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 54. Argentina AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 55. Middle East & Africa AI in diagnostics market, by country, 2021 - 2033 (USD Million)
  • Table 56. Middle East & Africa AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 57. Middle East & Africa AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 58. South Africa AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 59. South Africa AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 60. Saudi Arabia AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 61. Saudi Arabia AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 62. UAE AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 63. UAE AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 64. Kuwait AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 65. Kuwait AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market trends & outlook
  • Fig. 12 PESTLE analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 AI in diagnostics market: Component outlook and key takeaways
  • Fig. 15 AI in diagnostics market: Component movement analysis
  • Fig. 16 Software market, 2021 - 2033 (USD Million)
  • Fig. 17 Hardware market, 2021 - 2033 (USD Million)
  • Fig. 18 Services market, 2021 - 2033 (USD Million)
  • Fig. 19 AI in diagnostics market: Diagnosis type outlook and key takeaways
  • Fig. 20 AI in diagnostics market: Diagnosis type movement analysis
  • Fig. 21 Cardiology market, 2021 - 2033 (USD Million)
  • Fig. 22 Oncology market, 2021 - 2033 (USD Million)
  • Fig. 23 Pathology market, 2021 - 2033 (USD Million)
  • Fig. 24 Radiology market, 2021 - 2033 (USD Million)
  • Fig. 25 Chest and lung market, 2021 - 2033 (USD Million)
  • Fig. 26 Neurology market, 2021 - 2033 (USD Million)
  • Fig. 27 Others market, 2021 - 2033 (USD Million)
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 Regional outlook, 2025 & 2033
  • Fig. 30 AI in diagnostics market: Region movement analysis
  • Fig. 31 North America AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 32 US AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 33 Key country dynamics
  • Fig. 34 Canada AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 Mexico AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Europe AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 39 UK AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 Germany AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 France AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Italy AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Spain AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Norway AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Denmark AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamic
  • Fig. 53 Sweden AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Asia Pacific AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 56 Japan AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 China AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 India AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Australia AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 South Korea AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Thailand AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Latin America AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 69 Brazil AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Argentina AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Middle East and Africa AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 74 South Africa AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Saudi Arabia AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 UAE AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Kuwait AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Company categorization
  • Fig. 83 Strategy mapping
  • Fig. 84 Company market position analysis